Clinical trial Recruiting at 1 site Observational Ages 18 and up

Sleep patterns in psoriatic arthritis and SAPHO syndrome

Official title: Typological Study of Sleep Pathologies During Psoriatic Rheumatism and SAPHO Syndrome: Prospective Study Within the Paris Saint-Joseph Hospital Group"

Run by Fondation Hôpital Saint-Joseph · NCT07086599 · Data updated 2026-11-12

This project will see how sleep problems, including breathing-related sleep disorders, occur in adults with psoriatic arthritis or SAPHO syndrome who need hospital sleep evaluation.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorFondation Hôpital Saint-Joseph
Academic / other
Locations1 site (Paris)
StatusRecruiting
StartedNovember 13, 2023
Main results expectedMay 13, 2027
Study endsNovember 1, 2027
Registry record updatedJuly 25, 2025
Trial IDNCT07086599 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with a confirmed diagnosis of psoriatic arthritis or SAPHO syndrome who are followed at Paris Saint-Joseph Hospital, speak French, and require hospitalization for further sleep investigation are ideal candidates.

Probably not a fit

Patients already followed for a sleep disorder, those who had polysomnography within the last two years, end-of-life patients, or those under legal protection or deprived of liberty are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective observational project conducted at Hôpital Paris Saint-Joseph that enrolls adults with diagnosed psoriatic arthritis or SAPHO syndrome who present sleep complaints warranting inpatient evaluation. Enrolled patients will undergo hospital-based sleep investigations, likely including questionnaires and polysomnography or other sleep recordings, to characterize types and severity of sleep pathologies. Patients already followed for a sleep disorder or who had polysomnography in the past two years are excluded. No experimental treatments are given; data will be used to describe sleep disorder patterns and their relationship with pain and inflammatory disease features.

Why it matters

Potential benefit: If successful, the results could lead to better detection and management of sleep disorders in people with psoriatic arthritis or SAPHO, potentially improving sleep quality and pain control.

How similar studies have gone: Previous observational work has linked inflammatory rheumatism to poor sleep and increased rates of sleep apnea, but detailed typological data specifically in psoriatic arthritis and SAPHO syndrome remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient aged 18 years or older
* Patient diagnosed with psoriatic arthritis or SAPHO syndrome and followed at Paris Saint-Joseph Hospital
* Patient presenting sleep disorders warranting hospitalization for further -investigation of these disorders
* French-speaking patient
* Patient who does not oppose participation in the research protocol

Exclusion Criteria:

* Patient already followed for a sleep disorder
* Patient who underwent polysomnography in the last 2 years
* End-of-life patient
* Patient under guardianship or curatorship
* Patient deprived of liberty
* Patient under legal protection

Where it's running

  • Hôpital Paris Saint Joseph
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.